# FDA Inspection 1015263 - Ultragenyx Pharmaceutical Inc. - June 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/ultragenyx-pharmaceutical-inc/d5c7d3c8-6d16-43a6-9227-06fd3ae78ce0
Source feed: FDA_Inspections

> FDA Inspection 1015263 for Ultragenyx Pharmaceutical Inc. on June 20, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015263
- Company Name: Ultragenyx Pharmaceutical Inc.
- Inspection Date: 2017-06-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1277227 - 2025-07-17](https://www.keypedia.com/records/fda_inspections/ultragenyx-pharmaceutical-inc/328755e7-d412-4def-b423-f38d21b1a7b8)
- [FDA Inspection 1277227 - 2025-07-17](https://www.keypedia.com/records/fda_inspections/ultragenyx-pharmaceutical-inc/5630a73e-826a-4c90-b3a6-9bd1313a6920)
- [FDA Inspection 1199790 - 2023-02-27](https://www.keypedia.com/records/fda_inspections/ultragenyx-pharmaceutical-inc/44276fa6-30e1-4cba-89ea-213ede006e1f)

Company: https://www.keypedia.com/companies/ultragenyx-pharmaceutical-inc/52e0a912-e566-4a1d-89b4-822a2feaf1d0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c